GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Social Capital Suvretta Holdings Corp III (NAS:DNAC) » Definitions » EBITDA Margin %

Social Capital Suvretta Holdings III (Social Capital Suvretta Holdings III) EBITDA Margin % : 0.00% (As of Dec. 2021)


View and export this data going back to 2021. Start your Free Trial

What is Social Capital Suvretta Holdings III EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Social Capital Suvretta Holdings III's EBITDA for the six months ended in Dec. 2021 was $0.00 Mil. Social Capital Suvretta Holdings III's Revenue for the six months ended in Dec. 2021 was $0.00 Mil. Therefore, Social Capital Suvretta Holdings III's EBITDA margin for the quarter that ended in Dec. 2021 was 0.00%.


Social Capital Suvretta Holdings III EBITDA Margin % Historical Data

The historical data trend for Social Capital Suvretta Holdings III's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Social Capital Suvretta Holdings III EBITDA Margin % Chart

Social Capital Suvretta Holdings III Annual Data
Trend Dec21
EBITDA Margin %
-

Social Capital Suvretta Holdings III Semi-Annual Data
Dec21
EBITDA Margin % -

Competitive Comparison of Social Capital Suvretta Holdings III's EBITDA Margin %

For the Shell Companies subindustry, Social Capital Suvretta Holdings III's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Social Capital Suvretta Holdings III's EBITDA Margin % Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Social Capital Suvretta Holdings III's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Social Capital Suvretta Holdings III's EBITDA Margin % falls into.



Social Capital Suvretta Holdings III EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Social Capital Suvretta Holdings III's EBITDA Margin % for the fiscal year that ended in Dec. 2021 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2021 )/Revenue (A: Dec. 2021 )
=0/0
= %

Social Capital Suvretta Holdings III's EBITDA Margin % for the quarter that ended in Dec. 2021 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2021 )/Revenue (Q: Dec. 2021 )
=0/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Social Capital Suvretta Holdings III  (NAS:DNAC) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Social Capital Suvretta Holdings III EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Social Capital Suvretta Holdings III's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Social Capital Suvretta Holdings III (Social Capital Suvretta Holdings III) Business Description

Traded in Other Exchanges
N/A
Address
2850 W. Horizon Ridge Parkway, Suite 200, Henderson, NV, USA, 89052
Social Capital Suvretta Holdings Corp III is a blank check company.
Executives
Jennifer A. Fox director C/O NUVATION BIO INC., 1500 BROADWAY, SUITE 1401, NEW YORK NY 10036
Sc Pipe Holdings Llc 10 percent owner 506 SANTA CRUZ AVE., SUITE 300, MENLO PARK CA 94025
Tolerantia, Llc 10 percent owner 110 EAST 59TH STREET, SUITE 3300, NEW YORK NY 10022
Jimenez Santos Jose Ignacio director C/O PROKIDNEY CORP., 3929 WESTPOINT BLVD., SUITE G, WINSTON-SALEM NC 27103
Deepak Jain officer: Chief Operating Officer C/O PROKIDNEY CORP., 3929 WESTPOINT BLVD., SUITE G, WINSTON-SALEM NC 27103
Darin J. Weber officer: SVP of Regulatory Development C/O PROKIDNEY CORP., 3929 WESTPOINT BLVD., SUITE G, WINSTON-SALEM NC 27103
Libbie Parker Mckenzie officer: Chief Medical Officer C/O PROKIDNEY CORP., 3929 WESTPOINT BLVD., SUITE G, WINSTON-SALEM NC 27103
James Coulston officer: Chief Financial Officer C/O PROKIDNEY CORP., 3929 WESTPOINT BLVD., SUITE G, WINSTON-SALEM NC 27103
Sc Master Holdings, Llc 10 percent owner 506 SANTA CRUZ AVENUE, SUITE 300, MENLO PARK CA 94025
Alan Lotvin director 55 NOD ROAD, AVON CT 06001
Timothy Bertram director, officer: Chief Executive Officer C/O TENGION, INC., 2900 POTSHOP LANE, SUITE 100, EAST NORRITON PA 19403
Todd C Girolamo officer: Chief Legal Officer 110 ALLEN ROAD, 2ND FLOOR, BASKING RIDGE NJ 07920
Uma Sinha director C/O EIDOS THERAPEUTICS, INC., 101 MONTGOMERY STREET, SUITE 2550, SAN FRANCISCO CA 94101
Control Empresarial De Capitales S.a. De C.v. 10 percent owner INSURGENTES SUR #3500, PB, COL. PENA POBRE, DELEGACION TLALPAN, CP, MEXICO D.F. O5 14060
Pablo G. Legorreta director, 10 percent owner 110 E 59TH STREET, SUITE 3300, NEW YORK NY 10022

Social Capital Suvretta Holdings III (Social Capital Suvretta Holdings III) Headlines

From GuruFocus

ProKidney to present at upcoming investor conferences

By GuruFocusNews GuruFocusNews 05-30-2022

ProKidney to present at upcoming investor conferences

By GuruFocusNews GuruFocusNews 07-09-2022